ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 45 filers reported holding ADICET BIO INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $209,000 | -79.4% | 14,317 | -71.8% | 0.01% | -75.0% |
| Q1 2022 | $1,013,000 | -21.1% | 50,715 | -30.9% | 0.02% | -20.0% |
| Q4 2021 | $1,284,000 | +319.6% | 73,415 | +88.1% | 0.03% | +275.0% |
| Q3 2021 | $306,000 | +155.0% | 39,034 | +7.5% | 0.01% | +100.0% |
| Q2 2021 | $120,000 | -47.8% | 36,297 | -14.1% | 0.00% | -55.6% |
| Q1 2021 | $230,000 | -35.2% | 42,239 | +67.1% | 0.01% | -30.8% |
| Q4 2020 | $355,000 | +21.2% | 25,275 | +2.4% | 0.01% | -27.8% |
| Q3 2020 | $293,000 | – | 24,683 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 728,944 | $998,653 | 0.37% |
| DAFNA Capital Management LLC | 797,054 | $1,091,964 | 0.34% |
| COWEN AND COMPANY, LLC | 2,715,278 | $3,719,930 | 0.26% |
| Orbimed Advisors | 8,322,140 | $11,401,332 | 0.24% |
| TANG CAPITAL MANAGEMENT LLC | 1,226,352 | $1,680,102 | 0.24% |
| Carlyle Group Inc. | 2,115,385 | $2,876,924 | 0.12% |
| RTW INVESTMENTS, LP | 4,241,472 | $5,810,817 | 0.12% |
| Acuitas Investments, LLC | 136,779 | $187,387 | 0.11% |
| Decheng Capital Management III (Cayman), LLC | 200,201 | $274,275 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 142,168 | $195 | 0.02% |